NCT03452501 2021-02-23Safety and Effectiveness Study of Remsima® in the Treatment of Inflammatory Bowel Diseases Among Saudi Arabia PatientsHikma Pharmaceuticals LLCCompleted157 enrolled
NCT02376478 2015-03-03On the Impact of Therapeutic Tumor Necrosis Factor-alpha Inhibition on Anogenital Human Papillomavirus InfectionMedical University of ViennaCompleted222 enrolled